James Hunter
Patrimonio netto: - $ in data 31/08/2026
Patrimonio netto: - $ in data 31/08/2026
James Hunter is the founder of ReliaLAB, Inc. Current jobs include Director at Tonix Pharmaceuticals Holding Corp.
starting in 2025.
Former jobs include President & Chief Executive Officer at Validus Pharmaceuticals LLC from 2007 to 2018 and Executive Director-Northeast Business Unit at Ciba-Geigy Pharmaceuticals.
Education includes an MBA from Fairleigh Dickinson University and an undergraduate degree from Seton Hall University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/05/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Direttore/Membro del Consiglio | 12/06/2025 |
| Società | Posizione | Fine |
|---|---|---|
Validus Pharmaceuticals LLC
Validus Pharmaceuticals LLC Drugstore ChainsRetail Trade Develops and markets psychiatry and neurology products | Amministratore Delegato | 01/06/2018 |
Ciba-Geigy Pharmaceuticals | Corporate Officer/Principal | - |
ReliaLAB, Inc. | Fondatore | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
ReliaLAB, Inc. | |
Validus Pharmaceuticals LLC
Validus Pharmaceuticals LLC Drugstore ChainsRetail Trade Develops and markets psychiatry and neurology products | Retail Trade |
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seton Hall University
Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ciba-Geigy Pharmaceuticals | |
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics & diagnostics products to treat and prevent human disease and alleviate suffering | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale